momo-T/FIF Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : momo-T/FIF

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Tomato who wrote (429)	5/31/2004 11:33:24 AM
From: Mike McFarland	Read Replies (1) of 12215

Some of the tool companies are taking beatings. I'd add something like Sequenom, although even better, you might put it on a list to revist about a year from now, or in tax loss season. finance.yahoo.com I'd ask Tuck, what about something like Caliper? I've not followed their story these part few years at all, has anybody revisited that idea? It is a little interesting to see who is in the advertiser boxes in article such as this one: sciencemag.org Big ones like Agilent and ABI might do nicely in a market where big Nasdaq stocks do well, but small stocks lag. Likewise, if you wanted to be fully invested all the time, you could use an Amgen for the cash portion. Mutual funds have to be fully invested, hoarding dry powder would give your experiment an unfair advantage if you want to compare performance agaist biofunds a year from now. ABI trades at something like 18 times earnings, and has underperformed the Nasdaq recently. finance.yahoo.com^IXIC

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next